Winton Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-17,728
| Closed | -$5.93M | – | 620 |
|
|
2024
Q3 | $5.93M | Buy |
+17,728
| New | +$5.93M | 0.42% | 56 |
|
|
2022
Q2 | – | Sell |
-410
| Closed | -$231K | – | 951 |
|
|
2022
Q1 | $231K | Sell |
410
-2,671
| -87% | -$1.5M | 0.01% | 872 |
|
|
2021
Q4 | $2.33M | Buy |
3,081
+537
| +21% | +$406K | 0.14% | 180 |
|
|
2021
Q3 | $1.9M | Buy |
2,544
+411
| +19% | +$307K | 0.11% | 205 |
|
|
2021
Q2 | $1.37M | Buy |
2,133
+252
| +13% | +$162K | 0.07% | 354 |
|
|
2021
Q1 | $1.07M | Sell |
1,881
-857
| -31% | -$489K | 0.06% | 418 |
|
|
2020
Q4 | $1.6M | Sell |
2,738
-6,664
| -71% | -$3.88M | 0.12% | 187 |
|
|
2020
Q3 | $4.85M | Sell |
9,402
-14,813
| -61% | -$7.63M | 0.16% | 129 |
|
|
2020
Q2 | $10.9M | Buy |
24,215
+2,867
| +13% | +$1.29M | 0.28% | 31 |
|
|
2020
Q1 | $7.48M | Buy |
21,348
+19,587
| +1,112% | +$6.87M | 0.2% | 127 |
|
|
2019
Q4 | $652K | Sell |
1,761
-92,286
| -98% | -$34.2M | 0.01% | 1167 |
|
|
2019
Q3 | $31.3M | Buy |
94,047
+52,194
| +125% | +$17.4M | 0.37% | 87 |
|
|
2019
Q2 | $13.1M | Buy |
+41,853
| New | +$13.1M | 0.25% | 146 |
|
|
2018
Q4 | – | Sell |
-1,064
| Closed | -$333K | – | 872 |
|
|
2018
Q3 | $333K | Sell |
1,064
-28,396
| -96% | -$8.89M | 0.01% | 774 |
|
|
2018
Q2 | $8.5M | Buy |
29,460
+24,502
| +494% | +$7.07M | 0.22% | 184 |
|
|
2018
Q1 | $1.24M | Sell |
4,958
-17,375
| -78% | -$4.35M | 0.04% | 437 |
|
|
2017
Q4 | $5.33M | Buy |
+22,333
| New | +$5.33M | 0.15% | 247 |
|
|
2014
Q4 | – | Sell |
-1,786
| Closed | -$203K | – | 620 |
|
|
2014
Q3 | $203K | Sell |
1,786
-1,278
| -42% | -$145K | ﹤0.01% | 654 |
|
|
2014
Q2 | $367K | Buy |
+3,064
| New | +$367K | ﹤0.01% | 615 |
|